XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Kristie T. Burns  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On May 15, 2024, Kristie T. Burns, our Senior VP Marketing and Clinical Affairs, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 7,444 shares of our common stock in the aggregate and terminates on the earlier of the close of market on August 26, 2025, or the date all shares are sold thereunder.
Name Kristie T. Burns
Title Senior VP Marketing and Clinical Affairs
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 15, 2024
Expiration Date August 26, 2025
Aggregate Available 7,444
William W. Burke  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On May 28, 2024, William W. Burke, Chairman of our Board of Directors, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 7,013 shares of our common stock in the aggregate and terminates on the earlier of the close of market on December 31, 2025, or the date all shares are sold thereunder.
Name William W. Burke
Title Chairman of our Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 28, 2024
Expiration Date December 31, 2025
Aggregate Available 7,013
Elaine M. Birkemeyer  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On June 10, 2024, Elaine M. Birkemeyer, Chief Financial Officer, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 84,848 shares of our common stock in the aggregate and terminates on the earlier of the close of market on December 31, 2027, or the date all shares are sold thereunder.
Name Elaine M. Birkemeyer
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 10, 2024
Expiration Date December 31, 2027
Aggregate Available 84,848
Daniel L. Reuvers  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On June 10, 2024, Daniel L. Reuvers, former Chief Executive Officer and current member of our Board of Directors, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 130,564 shares of our common stock in

the aggregate and terminates on the earlier of the close of market on December 31, 2025, or the date all shares are sold thereunder.
Name Daniel L. Reuvers
Title former Chief Executive Officer and current member of our Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 10, 2024
Expiration Date December 31, 2025
Aggregate Available 130,564